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Abstract: Awake fiberoptic intubation is one of the recommended strategies for surgical patients with an-
ticipated difficult airway, especially when concurrent difficult ventilation is expected. We performed the
first systematic review of randomized controlled trials assessing different protocols for awake fiberoptic
intubation in anticipated difficult airway, including studies investigating elective awake fiberoptic intu-
bation for scheduled surgery; randomized controlled trials comparing different methods for performing
awake fiberoptic intubation; and adult patients with anticipated difficult airway. We excluded studies
in the nonoperating theater settings, randomized controlled trials comparing awake fiberoptic intuba-
tion with other techniques, and studies based on simulation. Primary outcomes were success rate and
death; secondary outcomes were major adverse events. Thirty-seven randomized controlled trials evalu-
ating 2045 patients and 4 areas were identified: premedication, local anesthesia, sedation, and ancillary
techniques to facilitate awake fiberoptic intubation. Quality of evidence was moderate-low and based
on small-sampled randomized controlled trials. Overall, 12 of 2045 intubation failures (0.59%) and 7 of
2045 severe adverse events (0.34%) occurred, with no permanent consequences or death. All evaluated
methods to achieve local anesthesia performed similarly well. No differences were observed in success rate
with different sedatives. Dexmedetomidine resulted in fewer desaturation episodes compared to propofol
and opioids with or without midazolam (relative risk, 0.51 [95% CI, 0.28-0.95]; P = .03); occurrence
of desaturation was similar with remifentanil versus propofol, while incidence of apnoea was lower with
sevoflurane versus propofol (relative risk, 0.43 [95% CI, 0.22-0.81]; P = .01). A high degree of efficacy and
safety was observed with minimal differences among different protocols; dexmedetomidine might offer a
better safety profile compared to other sedatives.
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racheal intubation is often required for surgical inter-
ventions. A certain number of patients presents diffi-
cult airway, defined as “the clinical situation in which 
a conventionally trained anesthesiologist experiences diffi-
culty with facemask ventilation of the upper airway, diffi-
culty with tracheal intubation, or both,”1 with an incidence 
ranging from 0.3% to 13%.2 Moreover, in up to 1 of every 250 
patients (0.4% of cases), difficult laryngoscopy and difficult 
mask ventilation might be associated, generating a risky sce-
nario known as “cannot intubate, cannot oxygenate”.3,4 As a 
matter of fact, severe brain damage and death can result from 
inappropriate management of a difficult airway;5,6 recently, a 
nationwide survey of compensation related to injuries after 
anesthesia and airway management in Norway revealed 
that more than half of the severe injuries were caused by 
failed intubation or a misplaced endotracheal tube.7
While difficult airway management can be an unex-
pected finding, several scores and tests with different per-
formances have been proposed to predict the risk of its 
occurrence.1,2,8 Different techniques to face anticipated dif-
ficult airway have been proposed and evaluated, and guide-
lines were published.1,2,9 In such a case, the so-called awake 
fiberoptic intubation, performed by anesthetization of the 
upper airway mucosa by topical local anesthesia or regional 
anesthesia, and frequently facilitated by the administration 
of sedatives (but preserving spontaneous breathing), has a 
crucial role, being considered the gold standard by national 
societies and experts.2,9–11 Different aspects of this technique 
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have been evaluated in randomized controlled trials, but no 
systematic review summarized their results.
We performed a systematic review of randomized con-
trolled trials comparing different techniques and medi-
cations for awake fiberoptic intubation for anticipated 
difficult airway in adult surgical patients. We hypothesized 
that techniques and medications for awake fiberoptic intu-




PubMed, BioMed Central, Embase, and the Cochrane 
Central Register of Clinical Trials were searched for perti-
nent studies (updated on March 21, 2018) by 5 investiga-
tors (M.B.R., M.F., M.P., A.P., C.D.V.). The detailed search 
strategy is reported in the Appendix A. The references of 
retrieved articles and pertinent reviews were checked for 
further studies. No language restriction was used.
Study Selection
References obtained from database and literature were 
first independently examined at title/abstract level by 6 
investigators (L.C., M.B.R., M.F., M.P., A.P., C.D.V.), with 
disagreement resolved by consensus with supervision of 4 
investigators (M.A., G.L., P.P., A.Z.) and, if potentially perti-
nent, full articles were retrieved.
The following inclusion criteria were used for potentially 
relevant studies: (1) elective awake fiberoptic intubation for 
any elective surgical procedure; (2) randomized controlled 
trials comparing different methods of premedication, seda-
tion, local anesthesia, and ancillary devices or techniques 
for fiberoptic bronchoscopy or tracheal tube introduction; 
(3) involving adult patients with anticipated difficult airway 
management; and (4) published in peer-reviewed journals. 
Exclusion criteria included nonoperating theater settings, 
randomized controlled trials comparing awake fiberoptic 
intubation with other techniques, and studies based on 
simulation. Three investigators (L.C., L.B., G.L.) selected 
studies for the final analysis independently assessing com-
pliance to selection criteria. Divergences were solved by 
consensus. Main outcomes were success rate, death, and 
potentially life-threatening adverse events.
Data Abstraction, Synthesis, and Study 
Characteristics
Data were independently extracted by 2 authors (M.B.R., 
M.F.) with disagreements resolved by discussion or involv-
ing a third reviewer when required. Two authors (L.C., 
L.B.) screened the trials for meaningful outcome measures 
that could be compared systematically. We computed the 
relative risks along with their 95% CIs for dichotomous 
outcomes. Pooled estimates were calculated with a mixed-
effects model using the DerSimonian–Laird method. We 
analyzed several small-sampled studies with zero events 
reported in both arms; to include them in the mixed-effects 
model avoiding loss of information, we added a constant 
(0.5) to the event counts in these studies. Studies were 
stratified to reduce clinical heterogeneity. We compared 
subgroups with the Cochrane Q test, and residual statistical 
heterogeneity was assessed with the I2 statistics and Q test. 
Meta-analyses were performed with R 3.2.3 and the meta-
for package (The R Foundation for Statistical Computing, 
Vienna, Austria; www.r-project.org).
The internal validity of each included trial was evalu-
ated for bias according to the Cochrane Collaboration meth-
ods by 2 authors (E.F., A.P.). We assessed the risk of bias 
associated with the random sequence generation, alloca-
tion concealment, blinding of participants and personnel, 
blinding of outcome assessment, completeness of outcome 
data, selective reporting, and other bias. We evaluated the 
potential risk of bias by applying a rating of “low,” “high,” 
or “unclear” to each study. For comparisons comprising >5 
studies, we performed a formal assessment of bias using a 
funnel plot.
Certainty of the body of evidence was assessed 
using the Grading of Recommendations Assessment, 
Development, and Evaluation framework.12 The Grading 
of Recommendations Assessment, Development, and 
Evaluation evaluation characterizes the certainty of a body 
of evidence on the basis of study limitations, imprecision, 
inconsistency, indirectness, and other considerations.13,14
The protocol was registered at Prospero database 
(CRD42018093009).
RESULTS
Database searches and references screening yielded 2150 
articles. Among these, we identified and retrieved 37 
randomized clinical trials for inclusion evaluating 2045 
patients with anticipated difficult airway management 
and scheduled for elective awake fiberoptic intubation. 
Four different areas of investigation could be identified: 
premedication (1 study),15 local anesthesia (10 studies),16–25 
sedation (23 studies),26–48 and other ancillary devices and 
techniques to facilitate awake fiberoptic intubation (3 stud-
ies).49–51 Random sequence generation was assessed as low 
risk of bias in 22 trials, allocation concealment in 6 trials, 
blinding of participants and personnel in 9 trials, blinding 
of outcome assessors in 12 trials, completeness of outcome 
data in 32 trials, selective outcome reporting in 35 trials, 
and other bias in 31 trials. Overall, 14 trials were judged 
to be at unclear risk and 23 at high risk (Supplemental 
Digital Content 1, Figures 1–2, http://links.lww.com/
AA/C749). Overall, 12 of 2045 intubation failures (0.59%) 
and 7 of 2045 severe adverse events (0.34%) were reported 
in the randomized controlled trials, all immediately and 
successfully treated; no adverse events resulting in per-
manent damage nor death occurred.
Within the different areas, a high degree of heterogene-
ity was present in terms of protocols and reported outcomes, 
namely markedly different dosages, different combination of 
drugs and techniques, scores applied to evaluate the ease of 
the procedure and patient satisfaction, and safety data. Hence, 
formal meta-analysis was restricted to success rate, incidence 
of desaturation, or apnoea with different sedation regimens.
In the only randomized controlled trial focused on 
premedication, Yokota et al15 compared premedication 
with atropine and hydroxyzine intramuscularly with oral 
clonidine in 30 patients: at intubation, the increase of sys-
tolic pressure and heart rate was less marked in the cloni-
dine group.
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Ten randomized controlled trials including 547 patients 
evaluated different techniques to perform topical anesthe-
sia (Table). Premedication, sedatives, and collected out-
comes were heterogeneous: no reliable meta-analysis could 
be performed. Safety and efficacy were high with all tech-
niques: only 4 of 547 failures (0.7%) were observed, with no 
reported severe adverse event.
Most of the available randomized controlled tri-
als assessed several sedation regimens in 1334 patients 
(Supplemental Digital Content 2, Table 1, http://links.
lww.com/AA/C750). With 14 studies, dexmedetomidine 
was the single most evaluated drug, both as single bolus 
or as continuous infusion. Opioids (fentanyl, sufentanil, 
and remifentanil) were evaluated in 12 studies as bolus or 
continuous infusion (manually set or as target-controlled 
infusion); often, they were associated with other sedatives, 
usually midazolam. Propofol was evaluated in 9 studies and 
infused as bolus or as continuous infusion (manually regu-
lated or as target-controlled infusion). Finally, sevoflurane 
was used in 2 studies, and etomidate was used in 1 study. 
Every randomized controlled trial reported significant 
differences in some clinically secondary outcome among 
the evaluated drugs: in particular, when not associated to 
benzodiazepines, opioids seemed to cause a higher inci-
dence of recall compared to dexmedetomidine and propo-
fol. However, all regimens showed a similarly satisfactory 
level of efficacy, with only 8 of 1334 (0.60%) reporting failed 
intubations, and high level of safety, with 7 of 1334 (0.52%) 
reported severe adverse events. Overall, dexmedetomi-
dine, compared to sedation regimes based on propofol, 
opiates, benzodiazepines, or their combinations, resulted 
in fewer desaturation episodes (relative risk, 0.51; 95% CI, 
0.28–0.95; P = .03; I2 = 0%; Grading of Recommendations 
Assessment, Development, and Evaluation level of evi-
dence: low; Figure  1; funnel plot in Supplemental Digital 
Content 1, Figure 3, http://links.lww.com/AA/C749), but 
no differences were observed in the incidence of proce-
dure failure (relative risk, 0.99; 95% CI, 0.29–3.37; P = .98; 
I2 = 0%). Remifentanil compared to propofol was associ-
ated with similar incidence of desaturation episodes (rela-
tive risk, 0.28; 95% CI, 0.04–1.92; P = .18; I2 = 0%; Grading 
of Recommendations Assessment, Development, and 
Evaluation level of evidence: low; Figure 2) and procedural 
failure (relative risk, 0.65; 95% CI, 0.11–3.96; P = .64; I2 = 0%; 
Grading of Recommendations Assessment, Development, 
and Evaluation level of evidence: low). Sevoflurane com-
pared to propofol was associated with fewer episodes of 
apnea (relative risk, 0.43; 95% CI, 0.22–0.81; P = .01; I2 = 0%; 
Grading of Recommendations Assessment, Development, 
and Evaluation level of evidence: low; Figure 3) and similar 
procedural failure rate (relative risk, 2.90; 95% CI, 0.44–18.96; 
P = .27; I2 = 0%; Grading of Recommendations Assessment, 
Development, and Evaluation level of evidence: low).
Finally, 3 studies evaluated other devices and tech-
niques to facilitate the procedure.49–51 Bourgain et al,49 
using an endoscopy mask (VBM-Medical, Sulz am Neckar, 
Germany), compared the application of 10 cm H2O of pres-
sure support with spontaneous breathing without support 
in a total of 32 patients sedated with propofol; the supported 
group showed a significantly higher minute ventilation 
but longer duration of the procedure, while other param-
eters were similar.49 Zou et al50 compared a prototype mask 
designed for endoscopy with conventional nasal oxygen 
therapy in 54 patients: the mask group had a significantly 
better peripheral oxygen saturation and fewer episodes of 
desaturation <90%.50 Mohammadzadeh et al,51 in 48 mildly 
sedated patients, compared the nasal introduction of the 
tube only when the fiberoptic bronchoscopy reached the 
vocal cords with a previous introduction of the tube through 
a nostril for 18 cm (scope first versus tube first): the latter 
group required less time and fewer facilitating maneuvers.51
DISCUSSION
The present study is the first systematic review and meta-
analyses of randomized controlled trials assessing different 
approaches in any phase of awake fiberoptic intubation for 
anticipated difficult airway in patients scheduled for elec-
tive surgery. Thirty-seven studies focusing on 4 different 
areas of this procedure (premedication, local anesthesia, 
sedation, and other ancillary devices and techniques to 
facilitate awake fiberoptic intubation) were included in this 
systematic review, while 15 were included in the meta-anal-
yses. The present study suggests that different methods for 
performing awake fiberoptic intubation are similarly safe 
and effective: we could not identify a protocol clearly better 
than the others, excluding some advantage on minor out-
comes for sedation protocols based on dexmedetomidine 
or sevoflurane. Moreover, our review observed a high level 
of efficacy and safety in the evaluated protocols despite the 
anticipated difficult airway management, with an over-
all success rate of 99.4%, no deaths, and an incidence of 
severe adverse events of 0.34% without reported permanent 
sequelae, confirming that awake fiberoptic intubation can 
be considered a reliable and well-tolerated option in this 
challenging condition of expected severe difficult airway 
management.
When facing a predicted difficult airway management 
and tracheal intubation is necessary, awake fiberoptic intu-
bation is still considered the standard approach, above all 
if mask ventilation is expected to be difficult.2,53 Preserving 
spontaneous breathing, awake fiberoptic intubation can 
prevent the risk of a critical desaturation or a “cannot intu-
bate-cannot oxygenate” scenario. In the setting of expected 
difficult airways, with particular reference to difficult or 
impossible ventilation,5–7 awake fiberoptic intubation is 
highly reliable, with a low number of (mostly mild) com-
plications53 and a variable success rate ranging from 88% to 
100%,1 mostly related to the operator’s experience
The awake fiberoptic intubation technique can be pre-
ceded by 3 subsequent steps: premedication, local anesthe-
sia, and sedation; furthermore, the insertion of the fiberoptic 
bronchoscopy and the tube can be performed in different 
ways. A detailed description of the procedure can be found 
elsewhere.53 Our aim was to identify the best approach of 
every step if sufficient data were available, to further improve 
awake fiberoptic intubation effectiveness and safety and 
orient future research. We found a wide heterogeneity of 
techniques and drugs regimens, with interpretation of their 
results made difficult also by the reciprocal relationships 
among the different steps: for example, a well-conducted 
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Table.  Randomized Controlled Trials Comparing Different Local Anesthesia Methods for Elective Fiberoptic  








Nebulized 2% lidocaine 40 mL Nebulized 4% lidocaine 40 mL 14 13 Sodium citrate 30 mL orally, 
metoclopramide 10 mg, 
glycopyrrolate 0.3 mg, and 
ondansetron 4 mg IV
Woodruff  
et al17
Nebulized 1% lidocaine 40 mL Nebulized 2% lidocaine 40 mL 11 10 Sodium citrate 30 mL orally, 
metoclopramide 10 mg, 
glycopyrrolate 0.3 mg, and 
ondansetron 4 mg IV
Vasu  
et al18
Nebulized 4% lidocaine 10 mL using 
DeVilbiss Model 163 Atomizer 
(DeVilbiss Health care, Somerset, 
PA)
Transtracheal injection 4% lidocaine 
4 mL
16 17 Glycopyrrolate 0.2 mg IV; 2 
sprays of 10% lidocaine into 




Nebulized 4% lidocaine 4 mL Topical anesthesia of nasal mucosa 
with cotton swabs soaked with 
4% lidocaine + bilateral superior 
laryngeal nerve block (3 mL, 2%) 
+ translaryngeal block (2 mL, 4%) 
with lidocaine
24 24 Diazepam (10 mg orally), 
morphine (0.15 mg/kg IM), 
glycopyrrolate (0.2 mg IM), 
and 2–3 drops of 0.05% 




4% lidocaine 10 mL by ultrasonic 
nebulizer
Blocks with 2% lidocaine of bilateral 
superior laryngeal nerve and 
transtracheal instillation of 
lidocaine, plus viscous xylocaine 
gargles twice
25 25 Oral ranitidine 150 mg, 
glycopyrrolate 5 μg/kg IM
Dhasmana 
et al21
2% lidocaine 10 mL by ultrasonic 
nebulizer
2% lidocaine 5 sprays in nasal cavity 
and nasopharynx, followed by 2% 
lidocaine with the spray-as-you-go 
technique (spray on the supraglottic 
areas, then glottic area, and finally 
below the cords)
30 30 IV glycopyrrolate 0.004 mg/kg 
and ondansetron 0.08 mg/
kg. 0.1% xylometazoline 2 
drops in each nostril
Xue et al22 2% lidocaine spray-as-you-go 
technique (spray on the 
supraglottic areas, then laryngeal 
area, and finally below the cords)
4% lidocaine spray-as-you-go 
technique (same technique)
26 26 Atropine 10 μg/kg IV + 5 




Nebulization of 4% lidocaine 2 mL 
on the vocal cords and then by 
2 mL of 4% lidocaine beneath 
the glottis by the fiberoptic 
bronchoscopy connected to the 
Enk Atomizer (Cook, Limerick, 
Ireland)
Translaryngeal injection of 4% 
lidocaine 4 mL
59 61 Midazolam 3.5–7 mg 1 h before 
surgery, orally. glycopyrrolate 
0.2 mg. 5 sprays of 10% 
lidocaine into the oral cavity 




2% lidocaine by the fiberoptic 
bronchoscopy connected to the 
Enk Atomizer (Cook, Limerick, 
Ireland), injected along all the 
passages from nostril to vocal 
cords
2% lidocaine with the spray-as-you-go 
technique (spray 5 mL on the 
laryngeal area, and then below the 
cords)
48 48 Oral benzodiazepine; 2% 
lidocaine 1 mL plus 0.25% 
phenylephrine in each 
nostril; one 10% lidocaine 
spray was applied twice onto 
the oropharynx.
Ambi et al25 Ultrasound-guided block of internal 
branch of the superior laryngeal 
nerve with 2% lidocaine 1 mL
Anatomical landmark-guided block 
of internal branch of the superior 
laryngeal nerve with 2% lidocaine 
1 mL
20 20 Nebulization with 3 mL of 4% 
lidocaine over 10 min, IV 
glycopyrrolate 10 μg/kg
The thick horizontal lines separate similar comparisons.
Abbreviations: BIS: bispectral index; ETCO2, end-tidal carbon dioxide; HR, heart rate; IM, intramuscularly; IV, intravenous; MAP, mean arterial pressure.
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Main Findings and Statistically  
Significant Differences
Midazolam and fentanyl 100% 100% 0 0 No differences between groups in 
hemodynamics, in time to airway 
topicalization and in time for airway 
manipulation between the 2 study groups. 
Peak plasma lidocaine concentration was 
higher in the 4% group without signs of 
toxicity.
Midazolam 1–2 mg + 
fentanyl 100–150 μg
100% 100% 0 0 2% lidocaine group showed shorter time for 
intubation, better operator’s satisfaction, and 
better patients’ tolerance, but higher peak 
plasma lidocaine concentrations, without 
signs of toxicity. Hemodynamic response was 
not different.
IV fentanyl 1–2 µg/kg in 
incremental doses
100% 100% 0 0 Transtracheal injection resulted in lesser 
patient discomfort, faster intubation, and 
comparable hemodynamic.
Incremental doses of 2.5 
mg of diazepam IV
100% 100% 0 0 No difference in intubation time or ETCO2 level 
after intubation. A higher HR and MAP 
increases were observed in the nebulized 
lidocaine group. No differences in nasal 
bleeding between the 2 groups.
Midazolam 20 μg/kg + 
fentanyl 1 μg/kg IV
100% 100% 0 0 The nebulization group showed a longer time to 
intubation, worse local cord opening, a higher 
incidence of cough and gag, a higher demand 
of supplemental lidocaine. No differences in 
hemodynamics.
Midazolam 0.05 mg/kg 
and fentanyl 2 μg/kg
100% 100% 0 0 No differences in hemodynamics and 
oxygenation. The nebulization group was 
more comfortable and required less 
lidocaine.
Fentanyl 1.5 μg/kg + 
midazolam
100% 100% 0 0 No difference in comfort score and coughing 
score, in total intubation time and 
hemodynamic. Higher total dosage of 
lidocaine was used in the 4% group.
Midazolam as clinically 
required
95% (3 failures) 100% 0 0 The translaryngeal technique was faster and 
showed less gagging and coughing, but 
presented more tracheal mucosal bleedings. 
No differences in hemodynamics, operators’ 
satisfaction, pain, hoarseness, difficulty of 
swallowing, or recall
Sufentanil bolus (<60 kg: 
5 μg; >60 kg: 10 μg; 
>100 kg: 15 μg)
98% (1 failure) 100% 0 0 Patients’ comfort was better using the atomizer 
technique, with fewer coughs or severe 
coughing episodes. The atomizer technique 
was quicker with less lidocaine administration 
and a lower incidence of nasal pain 4 wk after 
surgery. No differences in terms gagging, 
grimacing or defensive movements, oxygen 
saturation, HR, blood pressure, depth of 
sedation, or BIS
Midazolam 0.03 mg/kg 100% 100% 0 0 Ultrasound-guided block showed a lower 
incidence of coughing and gagging, a shorter 
time to intubation, more stable hemodynamic 
and better patient’s tolerance
Table. Continued
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mild sedation can limit the role of the different local anes-
thesia techniques under evaluation and hence can generate 
similar outcomes, and vice versa an optimal local anesthesia 
can make undetectable the potential differences of the eval-
uated sedatives. Nevertheless, sedation could be considered 
complementary to an adequate local anesthesia.
Ten studies compared different approaches to local 
anesthesia, including nebulization of lidocaine (with dif-
ferent dosages and devices), regional nerve blocks, and 
spray-as-you-go technique.  Meta-analytic quantitative 
synthesis of data was hampered by the wide differences in 
premedication, administered sedatives, and collected out-
comes. Regional blocks seem faster and slightly superior to 
the other approaches, but also more invasive and requiring 
experience; nebulization is easy and seems at least not infe-
rior to the spray-as-you-go technique. However, no severe 
adverse event was reported with all the approaches, and all 
but 4 intubations could be completed.
Most of the available randomized controlled trials were 
focused on sedation. The administration of sedatives for 
Figure 1. Forest plot for occurrence of desaturation episodes during awake fiberoptic intubation according to sedation protocol. Dexmedetomidine 
is compared to sedation protocols based on opiates, opiates plus benzodiazepines, or propofol. df indicates degrees of freedom.
Figure 2. Forest plot for occurrence of desaturation episodes during awake fiberoptic intubation with sedation protocols based on remifentanil 
versus propofol. df indicates degrees of freedom.
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awake fiberoptic intubation aims to improve patient’s 
comfort and cooperation, possibly making the procedure 
easier and safer (eg, reducing the hemodynamic response); 
on the other hand, spontaneous breathing must be pre-
served, and aspiration prevented.2,53 Different drugs, with 
different dosages, administration techniques, and associa-
tions, have been evaluated in randomized controlled trials, 
and a clear superiority of one over the others could not be 
found, except for a lower incidence of episodes of desatu-
ration or apnea using dexmedetomidine or sevoflurane; all 
regimens allowed a satisfactory level of efficacy and safety. 
Dexmedetomidine is the most studied drug in this setting; 
2 recent meta-analyses54,55 performed on 4 and 13 studies, 
respectively, concluded that dexmedetomidine was effec-
tive, well tolerated, and associated with better intubation 
conditions and reduced recall. Our systematic review of ran-
domized controlled trials supports the safety and efficacy 
of dexmedetomidine and suggests some superiority when 
compared to propofol (in terms of ease of intubation and 
patient comfort) or opioids if used without benzodiazepines 
(in terms of postprocedure recall), even if a formal meta-
analysis was not feasible for these clinically relevant out-
comes; however, episodes of severe bradycardia can occur 
with dexmedetomidine. Opioids, administered as bolus or 
continuous infusion at the reported dosages, appear safe 
and effective with some advantage in reducing coughing 
and gag reflex; a high incidence of recall when they are used 
alone (particularly remifentanil), compared to dexmedeto-
midine or propofol, seems evident and has been already 
reported,56 suggesting the need of a cautious association 
with benzodiazepines like midazolam as premedication 
or sedative (a frequently applied regimen in the analyzed 
randomized controlled trials). Moreover, the availability of 
antagonists of opioids and benzodiazepines can enhance 
their safety. Propofol and sevoflurane appeared similar 
when compared, but the use of sevoflurane is technically 
challenging and potentially associated with environmental 
contamination: only 1 of the 2 randomized controlled trials 
performed awake fiberoptic intubation through a dedicated 
mask.46 Of note, no randomized controlled trial evaluated 
the use of benzodiazepines alone and above all the use of 
ketamine, whose analgesic properties could be of interest.
Among the other 4 retrieved studies, 3 reported isolated 
interventions without relevant results; on the contrary, the 
findings by Zou et al50 on the usefulness of an intubating 
mask and noninvasive ventilation in improving oxygen-
ation could be of interest in hypoxemic patients. The poten-
tial role of noninvasive ventilation during non–fiberoptic 
bronchoscopy-guided tracheal intubation of critically ill 
patients has been recently underlined,57 but, so far, no ran-
domized controlled trial evaluated awake fiberoptic intu-
bation and noninvasive ventilation in hypoxemic patients 
with anticipated difficult airway. Interesting and promis-
ing data come from us of high-flow nasal cannula as mean 
of procedural oxygenation during fiberoptic intubation of 
difficult airway patients.58 Based on our findings, awake 
fiberoptic intubation in anticipate difficult airway appears 
safe and effective under a wide range of protocols, with an 
incidence of severe adverse events or failures well below 
1%. These data support the role of awake fiberoptic intuba-
tion as standard in this setting, considering the severity of 
the potential consequences in cannot intubate, cannot oxy-
genate conditions after induction of general anesthesia and 
suppression of spontaneous breathing.5–7 As a consequence, 
training of anesthesiologist on awake fiberoptic intubation 
and familiarity with the local protocol should be considered 
a priority; unfortunately, there is evidence indicating unde-
ruse of awake fiberoptic intubation5 and a certain reluctance 
by anesthetists because of unsatisfactory training and teach-
ing.10,52 Virtual simulators and manikins could be of help.53
The present review has some limitations. Its main limita-
tion is the inability to perform a formal synthesis of most 
of its findings to identify the best approach for every step 
of awake fiberoptic intubation due to the heterogeneity of 
Figure 3. Forest plot for occurrence of apnea episodes during awake fiberoptic intubation with sedation protocols based on sevoflurane versus 
propofol. df indicates degrees of freedom.
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the available studies; we performed a meta-analysis only 
for few, more homogeneous results, and its findings should 
be interpreted with caution. Moreover, given that the suc-
cess rate was very high and the complications were very 
rare in all the randomized controlled trials, no specific 
strategy could be declared superior to the others and larger 
studies are required; furthermore, major life-threatening 
adverse events were collected in the different randomized 
controlled trials without homogeneous definitions. A sec-
ond limit is the relatively low number of patients included 
in all randomized controlled trials. Our systematic review 
was focused on awake fiberoptic intubation; recently, other 
techniques (in particular video laryngoscopy) for awake 
intubations were evaluated and found to be feasible and 
safe.59 Even optimal use of awake fiberoptic intubation can-
not reach a success rate of 100%; alternative techniques in 
accordance with local and international guidelines should 
always be preplanned and promptly applied in case of 
awake fiberoptic intubation failure. On the other hand, our 
study has relevant strengths; it is the first systematic review 
on the topic, and it is based only on randomized controlled 
trials. To our knowledge, we describe the largest series of 
elective awake fiberoptic intubation, making our data origi-
nal and potentially useful to guide the clinician. Moreover, 
even if we were unable to clearly identify a protocol supe-
rior to others, our findings suggest that a wide range of 
approaches can be effective and safe, and this translates in 
a clear message for the clinician. Finally, the present review 
underlines the need in this field of shared outcomes instead 
of unvalidated qualitative scores; furthermore, we observed 
that potentially useful drugs (like ketamine) or techniques 
(like awake fiberoptic intubation through an intubating 
mask in hypoxemic surgical patients) have never or poorly 
evaluated.
In conclusion, in the first systematic review of random-
ized controlled trials focused on awake fiberoptic intuba-
tion in elective surgical patients with anticipated difficult 
airway, we found 37 randomized controlled trials includ-
ing 2045 patients. Most studies compared different tech-
niques of providing local anesthesia or sedation. All the 
approaches resulted highly safe and effective, confirming 
the relevance and reliability of awake fiberoptic intubation, 
although periprocedural protocols were highly heteroge-
neous. All described methods to achieve local anesthesia 
performed similarly well. Dexmedetomidine for sedation 
might be slightly safer to propofol and opioids with or 
without midazolam. Further, larger studies are required to 
identify the impact of procedural protocols on major clinical 
outcomes. E
APPENDIX A: SEARCH STRATEGY
(bronchoscop*[tiab] OR “fiber optic”[tiab] OR 
fiberoptic[tiab] OR “fibre optic”[tiab] OR fibreoptic[tiab]) 
AND (intubat*[tiab] OR airtraq[tiab] OR airway[tiab] 
OR device[tiab] OR ambu[tiab] OR pressure[tiab] OR 
bonfils[tiab] OR bullard[tiab] OR manoeuvre[tiab] OR 
maneuver[tiab] OR “c-mac”[tiab] OR combitube[tiab] 
OR cricothyroidotomy[tiab] OR cricothyrotomy[tiab] OR 
“c trach”[tiab] OR mask[tiab] OR ventilation[tiab] OR 
catheter[tiab] OR glidescope[tiab] OR bougie[tiab] OR 
“i-gel”[tiab] OR laryngeal[tiab] OR oesophageal[tiab] 
OR esophageal[tiab] OR tracheal[tiab] OR “LMA 
supreme”[tiab] OR manujet[tiab] OR McCoy[tiab] 
OR McGrath[tiab] OR obesity[tiab] OR fastrach[tiab] 
OR “pentax AWS”[tiab] OR “ProSeal LMA”[tiab] OR 
quicktrach[tiab] OR ramping[tiab] OR cannula[tiab] OR 
injector[tiab] OR introducer[tiab] OR trachview[tiab] OR 
laryngoscop*[tiab] OR “supraglottic airway device”[tiab] 
OR macintosh[tiab] OR “tracheal tube”[tiab] OR “endotra-
cheal tube”[tiab] OR “positive-pressure respiration”[tiab] 
OR “continuous positive airway pressure”[tiab] OR 
“neuromuscular blocking agents”[tiab] OR “neuromus-
cular blockade”[tiab] OR sedat*[tiab] OR “oxygen inha-
lation therapy”[tiab] OR insufflation[tiab] OR “high 
flow nasal cannula”[tiab] OR preoxygenation[tiab] OR 
“noninvasive ventilation”[tiab] OR stylet[tiab]) AND 
(anesthesia[tiab] OR anaesthesia[tiab] OR theatre[tiab] 
OR theater[tiab] OR room[tiab] OR intra operat*[tiab] 
OR intraoperat*[tiab] OR surg*[tiab] OR acute [tiab] OR 
emergen*[tiab] OR “lung injury”[tiab] OR “respiratory 
insufficiency”[tiab] OR “respiratory failure”[tiab] OR 
“airway obstruction”[tiab] OR asphyxia[tiab] OR “diffi-
cult airway”[tiab] OR hypoxia[tiab] OR hypoxemia[tiab] 
OR hypercapnia[tiab] OR “cardiac arrest”[tiab] OR 
asystole[tiab] OR anaphylaxis[tiab]) AND (randomized 
controlled trial[pt] OR controlled clinical trial[pt] OR ran-
domized controlled trials[mh] OR random allocation[mh] 
OR “double-blind” [tiab] OR single-blind method[mh] 
OR clinical trial[pt] OR clinical trials[mh] OR (clinical 
trial[tw] OR ((singl*[tw] OR doubl*[tw] OR trebl*[tw] 
OR tripl*[tw]) AND (mask*[tw] OR blind[tw])) OR 
(latin square[tw]) OR placebos[mh] OR placebo*[tw] OR 
random*[tw] OR research design[mh:noexp] OR compara-
tive study[tw] OR follow-up studies[mh] OR prospective 
studies[mh] OR crossover studies[mh] OR control[tw] 
OR controls[tw] OR controlled[tw] OR prospectiv*[tw] 
OR volunteer*[tw]) NOT (animal[mh] NOT human[mh]) 
NOT (comment[pt] OR editorial[pt] OR meta-analysis[pt] 
OR meta-analysis[tiab] OR practice-guideline[pt] OR 
review[pt] OR pediatrics[mh] OR pediatric[tiab] OR 
infants[tiab] OR children[tiab])). 
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